The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Gallus C, Ayuk F, Beckhove P, Besser D, Bornhäuser M, Büning H, Cantz T, Conrad C, Eichmüller S, Gazlig T, Graessner H, Grüters-Kieslich A, Huber N, Hudecek M, Kurz T, Lamprecht B, Luger E, Protzer U, Schambach A, Schäfer R, Serrano P, Stegemann S, Stöckert I, von Kalle C, Weber J, Baum C

Open source

DOI: 10.1177/10430342261464845
Published: 2026 Aug
Container: Human gene therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/10430342261464845,
  title = {The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.},
  author = {Gallus C and Ayuk F and Beckhove P and Besser D and Bornhäuser M and Büning H and Cantz T and Conrad C and Eichmüller S and Gazlig T and Graessner H and Grüters-Kieslich A and Huber N and Hudecek M and Kurz T and Lamprecht B and Luger E and Protzer U and Schambach A and Schäfer R and Serrano P and Stegemann S and Stöckert I and von Kalle C and Weber J and Baum C},
  year = {2026},
  journal = {Human gene therapy},
  doi = {10.1177/10430342261464845},
  url = {https://doi.org/10.1177/10430342261464845}
}

RIS

TY  - JOUR
TI  - The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.
AU  - Gallus C
AU  - Ayuk F
AU  - Beckhove P
AU  - Besser D
AU  - Bornhäuser M
AU  - Büning H
AU  - Cantz T
AU  - Conrad C
AU  - Eichmüller S
AU  - Gazlig T
AU  - Graessner H
AU  - Grüters-Kieslich A
AU  - Huber N
AU  - Hudecek M
AU  - Kurz T
AU  - Lamprecht B
AU  - Luger E
AU  - Protzer U
AU  - Schambach A
AU  - Schäfer R
AU  - Serrano P
AU  - Stegemann S
AU  - Stöckert I
AU  - von Kalle C
AU  - Weber J
AU  - Baum C
PY  - 2026
JO  - Human gene therapy
DO  - 10.1177/10430342261464845
UR  - https://doi.org/10.1177/10430342261464845
ER  -

APA

C, G., F, A., P, B., D, B., M, B., H, B., T, C., C, C., S, E., T, G., H, G., A, G., N, H., M, H., T, K., B, L., E, L., U, P., A, S., R, S., P, S., S, S., I, S., C, V. K., J, W., & C, B. (2026). The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.. Human gene therapy. https://doi.org/10.1177/10430342261464845

Source records

pubmed · retrieved 2026-09-25T17:48:02.032Z